13D Filings
BeiGene, Ltd.
ONC
Amendment
Ownership

6.70%

Total Shares

92,805,741

Issuer CIK

1651308

CUSIP

07725L102

Event Date

Mar 2, 2025

Accepted

Mar 3, 2025, 09:30 PM

Reporting Persons (2)
Joint Filing

This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.

NameType% of ClassAggregateSole VotingShared Voting
HHLR Advisors, Ltd.
Investment Adviser
6.70%92,805,741092,805,741
Hillhouse Investment Management, Ltd.
Investment Adviser
6.70%92,805,741092,805,741
Disclosure Items (2)

Security Title

Ordinary shares, par value $0.0001 per share

Issuer Name

BeiGene, Ltd.

Issuer Address

C/O MOURANT GOVERNANCE SERVICES (CAYMAN), GRAND CAYMAN, E9, KY1-1108

Percentage of Class

See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of Ordinary Shares and percentages of the Ordinary Shares beneficially owned by each Reporting Person. The percentage used in this Schedule 13D is calculated based upon 1,393,867,704 Ordinary Shares outstanding as of February 20, 2025, as reported in the Issuer's Amendment No. 2 to the Registration Statement on Form S-4, filed with the Securities and Exchange Commission on February 28, 2025.

Number of Shares

See rows (7) through (10) of the cover pages to this Schedule 13D for the number of Ordinary Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

Transactions

On March 3, 2025, HHLR Fund sold 2,480,000 ADSs pursuant to a block trade with Goldman Sachs & Co. LLC at a price of $244.50 per ADS.

BeiGene, Ltd. — Schedule 13D | 13D Filings